- Report
- March 2022
- 233 Pages
Global
From €2271EUR$2,496USD£1,929GBP
€3245EUR$3,565USD£2,756GBP
- Book
- October 2013
- 304 Pages
The Umbilical Cord Blood Stem Cell market is a subset of the larger Stem Cell market. Umbilical Cord Blood Stem Cells are derived from the umbilical cord and placenta of newborn babies. These cells are a rich source of hematopoietic stem cells, which can be used to treat a variety of diseases, including leukemia, lymphoma, and sickle cell anemia. They are also used in regenerative medicine, such as tissue engineering and cell therapy.
The Umbilical Cord Blood Stem Cell market is highly regulated, with strict guidelines for collection, storage, and distribution. Companies in this market must adhere to these regulations in order to remain compliant.
Some companies in the Umbilical Cord Blood Stem Cell market include Cryo-Cell International, Cord Blood Registry, and ViaCord. These companies provide umbilical cord blood stem cell collection, processing, and storage services. Show Less Read more